2024 annual financial data
Rocket Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -273,205,000 USD and net income was -258,746,000 USD.
Operating cash flow was -209,724,000 USD.
Get free Rocket Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -273,205,000 USD
- Net income
- -258,746,000 USD
- Operating cash flow
- -209,724,000 USD